Tag Archives: insulin

Drug middlemen illegally drive up the cost of insulin, FTC says, exposing a hidden layer of price manipulation in the pharmaceutical supply chain. These middlemen, who act as intermediaries between manufacturers and pharmacies, are accused of exploiting their position to inflate insulin prices, ultimately burdening patients and the healthcare system. …

Read More »